HOME >> BIOLOGY >> NEWS
New model of staph drug resistance implicates unlikely protein

Findings may lead to new drugs that overcome resistance

Researchers at The Rockefeller University have established a new model to explain how the infectious "staph" bacterium evades several widely used antibiotics. They show that a protein previously thought to play no role in drug resistance in Staphylococcus aureus is, in fact, essential.

The new study, which is co-authored by Mariana Pinho, Hermnia de Lencastre, Ph.D, and Alexander Tomasz, Ph.D., and appears in the August 21 online edition of the Proceedings of the National Academy of Sciences, emphasizes the importance of looking for new antibiotics that target this protein.

"Mariana's work shows that the old model of drug resistance in staphylococci is no longer tenable," says Tomasz, principal investigator of the research and professor at Rockefeller.

Since the introduction of antibiotics in the 1940s, Staphylococcus aureus, the number one cause of potentially life-threatening hospital-borne infections, has developed several mechanisms to beat the potentially lethal effects of chemotherapeutic agents. Of these bacterial tricks, the most important was the acquisition of a foreign gene - the mecA gene - that confers resistance to methicillin in addition to penicillin and a host of other antibiotics, all belonging to what scientists refer to as the beta-lactam class of antibiotics.

Today, almost half of all staphylococcal infections in U.S. hospitals are caused by these methicillin-resistant S. aureus (MRSA) strains. By studying the bacteria's resistance mechanisms at the molecular level, researchers in the Laboratory of Microbiology at Rockefeller, working with researchers in the Laboratory of Molecular Genetics at the Instituto de Tecnologia Qumica e Biolgica, Universidade Nova de Lisboa, Portugal, hope to come up with new strategies for fighting such resilient microbes.

The beta-lactam class of antibiotics kills bacteria by binding to and inacti
'"/>

Contact: Whitney Clavin
clavinw@rockefeller.edu
212-327-7900
Rockefeller University
21-Aug-2001


Page: 1 2 3

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
3. Computer models expose humans as main cause of caribou decline
4. New model can aid in understanding immune system diseases
5. Physics gravity model applicable to disease spread
6. BioMed Central to consult funders and librarians over Open Access payment model
7. Study reveals surprising remodeling property of gene regulation process
8. Gene therapy reaches muscles throughout the body and reverses muscular dystrophy in animal model
9. Genetic model for devastating form of paraplegia suggests new treatments
10. New model explains why costly insect outbreaks hard to predict
11. A genetic model for hereditary spastic paraplegia (HSP) disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/4/2017)... --  EyeLock LLC , a leader of iris-based identity ... and Trademark Office (USPTO) has issued U.S. Patent No. ... iris image with a face image acquired in sequence ... th issued patent. "The issuance ... multi-modal biometric capabilities that have recently come to market ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., a ... Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas ... practices and how Proscia improves lab economics and realizes an increase in diagnostic ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/11/2017)... TX (PRWEB) , ... October 11, 2017 , ... ... August compared the implantation and pregnancy rates in frozen and fresh in ... contribution of progesterone and maternal age to IVF success. , After comparing the ...
(Date:10/10/2017)... CALIF. (PRWEB) , ... October 10, 2017 , ... San ... part of its corporate rebranding initiative announced today. The bold new look is ... reach, as the company moves into a significant growth period. , It will also ...
Breaking Biology Technology:
Cached News: